"Attention of the Holders of Securities in Physical Mode is invited to Circular No. SEBI/HO/MIRSD/PoD-1/P/CIR/2023/181 dated November 17, 2023 issued by SEBI."
Home
About Us
Company Profile
Corporate ETHOS
Mission
Vision
Board of Directors and KMPs
Board Committees
Products
Speciality Chemicals
Skin Care Products
Hospital Care Products
Generics
Investors
Financial Information
Investor Information
Annual Reports
Shareholding Pattern
Corporate Governance
Policies
Other Data
Newsapaper Publication
Shareholders Meetings/Other Disclosures
Disclosure under Reg 46 of SEBI (LODR) Regulations 2015.
Media
News & Press Release
Contact Us
Q4
Closure of Trading Window
Announcement Under Regulation 31A(8)(A) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2022
Board Meeting Intimation for Approval Of The Un-Audited Financial Results For The Quarter Ended December 31, 2022
Announcement under Regulation 30 (LODR)-Memorandum of Understanding -Agreements
Announcement under Regulation 30 (LODR)-Resignation of Director
Board Meeting Outcome for Revised Outcome
Board Meeting Outcome for Board Meeting Held On 17Th January, 2023
Board Meeting Intimation for Allotment Of Equity Shares Issued On Preferential Basis
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Voting Results For Extraordinary General Meeting Held On 31St December, 2022
Home
About Us
Company Profile
Corporate ETHOS
Mission
Vision
Products
Personal Care Ingredients
Generics Ingredients
Hospital Care Products
Sking Care Products
Investors
Financial Information
Board of Directors
Annual Reports
Listing Updates
Shareholding Pattern
Corporate Governance
Half Yearly Compliances
Media
News & Press Release
Corporate Announcement
Gallery
Contact Us
